中华骨科杂志
中華骨科雜誌
중화골과잡지
CHINESE JOURNAL OF ORTHOPAEDICS
2014年
7期
769-776
,共8页
万广亮%付喆%杨建平%张中礼%王雯雯%崔爽爽%王侃%邓书贞%陈兆强
萬廣亮%付喆%楊建平%張中禮%王雯雯%崔爽爽%王侃%鄧書貞%陳兆彊
만엄량%부철%양건평%장중례%왕문문%최상상%왕간%산서정%진조강
髋脱位%骨疾病,发育性%超声检查
髖脫位%骨疾病,髮育性%超聲檢查
관탈위%골질병,발육성%초성검사
Hip dislocation%Bone diseases,developmental%Ultrasonography
目的 探讨Pavlik吊带治疗不同类型发育性髋脱位的临床效果,并分析复位失败的原因.方法 回顾性分析2009年1月至2013年3月,初始采用Pavlik吊带治疗髋关节脱位的163例(195髋)资料完整且随访超过1年的患儿资料,男18例(21髋),女145例(174髋);年龄18~129 d,平均(65.9±20.2)d;左侧85例,右侧46例,双侧32例;超声Graf分型:Ⅲ型165髋,Ⅳ型30髋.根据屈髋、外展时动态超声检查示能否复位及Ortolani试验,将髋关节脱位分为可复性及难复性两类.吊带佩戴3周后临床查体及超声检查仍示未复位或复位但不稳定者,视为吊带治疗失败.末次随访时摄骨盆正位X线片,并在其上测量髋臼指数,根据T(o)nnis标准判断残余髋臼发育不良,根据Salter标准判断股骨头缺血性坏死.分析年龄、性别、单双侧、脱位分类(可复性/难复性)及超声Graf分型与吊带复位效果的关系.结果 195髋中,144髋(73.8%,144/195)经吊带治疗复位成功;51髋(26.2%,51/195)复位失败,其中47髋再次行皮牵引后复位石膏固定治疗,4例4髋拒绝再治疗.163例患儿均获得随访,随访时间12~49个月,平均19个月.末次随访时,10髋(6.9%,10/144)残余髋臼发育不良,4髋(2.8%,4/144)发生股骨头坏死.单因素分析结果显示,复位成功率与年龄、性别及侧别无明显相关性,与超声分型(GrafⅢ:Ⅳ型,79.4%:43.3%)及脱位分类(可复性:难复性,79.1%:34.8%)有关.多因素分析结果显示,脱位分类(OR=6.071,P=0.000)及超声Graf分型(OR=4.629,P< 0.001)是影响复位成功的独立相关因素.GrafⅣ型且不可复性脱位仅12.5%(1/8髋)复位成功.结论 Pavlik吊带是早期治疗发育性髋关节脱位有效安全的方法之一,Pavlik吊带适用于GrafⅢ型可复性脱位,对Graf Ⅲ型难复性及Ⅳ型可复性脱位吊带复位失败率高,可尝试作为初始治疗的手段;GrafⅣ型难复性脱位不宜作为首选治疗方法.
目的 探討Pavlik弔帶治療不同類型髮育性髖脫位的臨床效果,併分析複位失敗的原因.方法 迴顧性分析2009年1月至2013年3月,初始採用Pavlik弔帶治療髖關節脫位的163例(195髖)資料完整且隨訪超過1年的患兒資料,男18例(21髖),女145例(174髖);年齡18~129 d,平均(65.9±20.2)d;左側85例,右側46例,雙側32例;超聲Graf分型:Ⅲ型165髖,Ⅳ型30髖.根據屈髖、外展時動態超聲檢查示能否複位及Ortolani試驗,將髖關節脫位分為可複性及難複性兩類.弔帶珮戴3週後臨床查體及超聲檢查仍示未複位或複位但不穩定者,視為弔帶治療失敗.末次隨訪時攝骨盆正位X線片,併在其上測量髖臼指數,根據T(o)nnis標準判斷殘餘髖臼髮育不良,根據Salter標準判斷股骨頭缺血性壞死.分析年齡、性彆、單雙側、脫位分類(可複性/難複性)及超聲Graf分型與弔帶複位效果的關繫.結果 195髖中,144髖(73.8%,144/195)經弔帶治療複位成功;51髖(26.2%,51/195)複位失敗,其中47髖再次行皮牽引後複位石膏固定治療,4例4髖拒絕再治療.163例患兒均穫得隨訪,隨訪時間12~49箇月,平均19箇月.末次隨訪時,10髖(6.9%,10/144)殘餘髖臼髮育不良,4髖(2.8%,4/144)髮生股骨頭壞死.單因素分析結果顯示,複位成功率與年齡、性彆及側彆無明顯相關性,與超聲分型(GrafⅢ:Ⅳ型,79.4%:43.3%)及脫位分類(可複性:難複性,79.1%:34.8%)有關.多因素分析結果顯示,脫位分類(OR=6.071,P=0.000)及超聲Graf分型(OR=4.629,P< 0.001)是影響複位成功的獨立相關因素.GrafⅣ型且不可複性脫位僅12.5%(1/8髖)複位成功.結論 Pavlik弔帶是早期治療髮育性髖關節脫位有效安全的方法之一,Pavlik弔帶適用于GrafⅢ型可複性脫位,對Graf Ⅲ型難複性及Ⅳ型可複性脫位弔帶複位失敗率高,可嘗試作為初始治療的手段;GrafⅣ型難複性脫位不宜作為首選治療方法.
목적 탐토Pavlik조대치료불동류형발육성관탈위적림상효과,병분석복위실패적원인.방법 회고성분석2009년1월지2013년3월,초시채용Pavlik조대치료관관절탈위적163례(195관)자료완정차수방초과1년적환인자료,남18례(21관),녀145례(174관);년령18~129 d,평균(65.9±20.2)d;좌측85례,우측46례,쌍측32례;초성Graf분형:Ⅲ형165관,Ⅳ형30관.근거굴관、외전시동태초성검사시능부복위급Ortolani시험,장관관절탈위분위가복성급난복성량류.조대패대3주후림상사체급초성검사잉시미복위혹복위단불은정자,시위조대치료실패.말차수방시섭골분정위X선편,병재기상측량관구지수,근거T(o)nnis표준판단잔여관구발육불량,근거Salter표준판단고골두결혈성배사.분석년령、성별、단쌍측、탈위분류(가복성/난복성)급초성Graf분형여조대복위효과적관계.결과 195관중,144관(73.8%,144/195)경조대치료복위성공;51관(26.2%,51/195)복위실패,기중47관재차행피견인후복위석고고정치료,4례4관거절재치료.163례환인균획득수방,수방시간12~49개월,평균19개월.말차수방시,10관(6.9%,10/144)잔여관구발육불량,4관(2.8%,4/144)발생고골두배사.단인소분석결과현시,복위성공솔여년령、성별급측별무명현상관성,여초성분형(GrafⅢ:Ⅳ형,79.4%:43.3%)급탈위분류(가복성:난복성,79.1%:34.8%)유관.다인소분석결과현시,탈위분류(OR=6.071,P=0.000)급초성Graf분형(OR=4.629,P< 0.001)시영향복위성공적독립상관인소.GrafⅣ형차불가복성탈위부12.5%(1/8관)복위성공.결론 Pavlik조대시조기치료발육성관관절탈위유효안전적방법지일,Pavlik조대괄용우GrafⅢ형가복성탈위,대Graf Ⅲ형난복성급Ⅳ형가복성탈위조대복위실패솔고,가상시작위초시치료적수단;GrafⅣ형난복성탈위불의작위수선치료방법.
Objective To evaluate the result of early treatment for developmental dislocation of the hips by Pavlik harness,and to seek the reasons of failure.Methods We retrospectively reviewed the patients of developmental dislocation of the hips who initially received Pavlik harness treatment between 2009 January and 2013 march by ultrasound examination.163 cases (195 hips) were collected complete data and followed up for more than 1 year.We combined the Ortolani test and ultrasound examination to determine whether the dislocated hip was reducible or irreducible.The ultrasound examinations were conducted every week after Pavlik harness treatment.If the reduction was not achieved in three weeks after Pavlik harness treatment confirmed by ultrasound examination,we determined the treatment was failure.A plain anteroposterior radiograph was taken for measuring the acetabular index at the last follow up and T(o)nnis Criterion was accorded to evaluate the residual dysplasia.The Salter Criterion was used to evaluate the avascular necrosis of femoral head.The relationships between age,gender,single-sided,reducibility,the ultrasonic type and reduction were analyzed.Results In 195 dislocated hips,144 hips (73.8%) were treated successfully by Pavlik harness,51 hips were failed with 49 hips were changed to the cast and 4 hips refused.The average time of follow-up was 19 months (12-49 months).At the last follow-up,10 hips (6.9%,10/144) were residual dysplasia,4 hips (2.8%,4/144) occurred avascular necrosis of the femoral head.Univariate analysis showed that there was no significant correlation between age,gender,singlesided and reduction (P > 0.05),but the ultrasonic type (Graf Type Ⅲ/Ⅳ,79.4% vs.43.3%) and the reducibility (reducible/irreducible,79.1%/34.8%) were relevant factors (P < 0.001).Multivariate analysis showed that the reducibility (OR=6.071,P=0.000)and ultrasonic type (OR=4.629,P < 0.001) were independent factors.Further analysis revealed that only 12.5% (1/8) of Graf Type Ⅳ with irreducible hips received reduction by harness.Conclusion Pavlik harness is an effective and safe method in early treatment of dislocated hips.Pavlik harness treatment applies for Graf Type Ⅲ reducible dislocated hips,and can be used as initial treatment for Graf Type Ⅲ with irreducible or Graf TypeⅣ and reducible dislocated hips which may have a higher failure rate.Pavlik harness should not be considered as the best choice for Graf Type Ⅳ irreducible dislocated hips.